You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

chronic hepatitis

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Hepatitis B Trial (RO7565020, Placebo, Nucleos(t)ide analogue (NUC) treatment)

Not yet recruiting
  • Chronic Hepatitis B
  • (no location specified)
Feb 28, 2023

Hepatitis B Trial in Seoul (DA-2803, DA-2803-R, Placebo of DA-2803)

Recruiting
  • Hepatitis B
  • Seoul, Korea, Republic of
    The Catholic University of Korea, Seoul
Jul 14, 2023

Chronic Hepatitis B Trial (HRS-5635, Placebo)

Not yet recruiting
  • Chronic Hepatitis B
  • (no location specified)
Mar 29, 2023

Chronic Hepatitis B Trial in Grafton (AHB-137 injection, Placebo)

Not yet recruiting
  • Chronic Hepatitis B
  • AHB-137 injection
  • Placebo
  • Grafton, Auckland, New Zealand
    New Zealand Clinical Research
Jan 29, 2023

Chronic HBV Infection Trial in Shenzhen (Peginterferon alfa-2b combined and ETV)

Recruiting
  • Chronic HBV Infection
  • Peginterferon alfa-2b combined and ETV
  • Shenzhen, China
    Shenzhen Third People Hospital
Mar 19, 2023

Hepatus and FibroScan for Evaluation of Fibrosis and Steatosis

Recruiting
  • Chronic Hepatitis b
  • Non-Alcoholic Fatty Liver Disease
    • Beijing, Select A State Or Province, China
      Yameng Sun
    Mar 27, 2023

    Chronic Hepatitis b Trial in Beijing, Chongqing (STSG-0002 Injection)

    Not yet recruiting
    • Chronic Hepatitis b
    • STSG-0002 Injection
    • Beijing, Beijing, China
    • +3 more
    Mar 6, 2023

    Chronic Hepatitis B and Hepatitis D Co-infection Trial in Changchun (HH-003 20mg/kg, HH-003 3mg/kg)

    Active, not recruiting
    • Chronic Hepatitis B and Hepatitis D Co-infection
    • HH-003 20mg/kg
    • HH-003 3mg/kg
    • Changchun, Jilin, China
      First Hospital of Jilin University
    Dec 30, 2022

    Chronic Hepatitis b, Anti-PD-1 Antibody, Peg-IFNa Trial in Chongqing (Anti-PD-1 antibody, NAs, Peg-IFNa)

    Not yet recruiting
    • Chronic Hepatitis b
    • +2 more
    • Anti-PD-1 antibody
    • +2 more
    • Chongqing, Chongqing, China
      The 2nd affiliated Hospital of Chongqing Medical University
    Mar 14, 2023

    Chronic Hepatitis b, Anti-PD-1 Antibody Trial in Chongqing (Anti-PD-1 antibody, NAs)

    Not yet recruiting
    • Chronic Hepatitis b
    • Anti-PD-1 Antibody
    • Anti-PD-1 antibody
    • NAs
    • Chongqing, Chongqing, China
      The 2nd affiliated Hospital of Chongqing Medical University
    Mar 3, 2023

    Chronic Hepatitis b Trial in Taiwan (Nuc Discontinuation, Entecavir or Tenofovir)

    Active, not recruiting
    • Chronic Hepatitis b
    • Nuc Discontinuation
    • Entecavir or Tenofovir
    • Chiayi City, Taiwan
    • +5 more
    Mar 30, 2023

    Chronic Hepatitis b Trial in Beijing, Chongqing (STSG-0002 Injection)

    Not yet recruiting
    • Chronic Hepatitis b
    • STSG-0002 Injection
    • Beijing, Beijing, China
    • +3 more
    Mar 6, 2023

    Chronic Hepatitis B Trial (GS-2829, GS-6779, Placebo for GS-2829)

    Not yet recruiting
    • Chronic Hepatitis B
    • GS-2829
    • +3 more
    • (no location specified)
    Mar 14, 2023

    Hepatitis B, Chronic Trial in Seoul (Vemliver tablet, Entecavir Tablet)

    Recruiting
    • Hepatitis B, Chronic
    • Vemliver tablet
    • Entecavir Tablet
    • Seoul, Korea, Republic of
      Seoul National University Hospital
    Aug 17, 2023

    Hepatitis b Virus Trial in New York (HepB mAb19, Sterile Saline)

    Not yet recruiting
    • Hepatitis b Virus
    • HepB mAb19
    • Sterile Saline
    • New York, New York
    • +1 more
    May 12, 2023

    Bulevirtide Therapy in HDV Chronic Hepatitis in Italy

    Completed
    • Hepatitis D
    • Milan, MI, Italy
      Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Divis
    Jul 24, 2023

    Chronic Hepatitis B:Multicenter Retrospective Cohort Study

    Recruiting
    • Hepatitis B, Chronic
      • Amsterdam, Netherlands
      • +2 more
      Jan 23, 2023

      Chronic Hepatitis C Virus, Hepatitis C, Chronic, Hepatitis C Trial in Bucuresti (Bemnifosbuvir, Ruzasvir)

      Recruiting
      • Chronic Hepatitis C Virus
      • +4 more
      • Bucuresti, BUC, Romania
        Atea Study Site
      Jun 15, 2023

      Bulevirtide Therapy in Chronic Hepatitis Delta in Italy

      Recruiting
      • Hepatitis D
      • Milan, MI, Italy
        Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Divis
      Nov 7, 2023

      Chronic Hepatitis b Trial (RBD1016, RBD1016+PegIFN-a)

      Not yet recruiting
      • Chronic Hepatitis b
      • (no location specified)
      Jul 25, 2023

      Chronic Hepatitis b Trial in Chongqing, Xi'an (Placebo, TQA3605 tablets, Entecavir dispersible tablets)

      Recruiting
      • Chronic Hepatitis b
      • Placebo
      • +4 more
      • Chongqing, Chongqing, China
      • +2 more
      Nov 27, 2023

      Hepatitis B, Chronic Trial in Auckland (VIR-3434, VIR-2218, TDF)

      Recruiting
      • Hepatitis B, Chronic
      • Auckland, New Zealand
      • +1 more
      Dec 19, 2022

      Hepatic Inflammation, Fibrosis and Prognosis in CHB and NAFLD

      Recruiting
      • Chronic Hepatitis b
      • Non-alcoholic Fatty Liver Disease
        • Nanjing, China
          Nanjing Drum Tower Hospital
        Mar 2, 2023

        Hepatitis B, Hepatitis B, Chronic Trial in Bamenda

        Active, not recruiting
        • Hepatitis B
        • Hepatitis B, Chronic
          • Bamenda, Northwest, Cameroon
            Mbingo Baptist Hospital
          Sep 13, 2022

          Chronic Hepatitis b Trial in Changchun (GST-HG141)

          Recruiting
          • Chronic Hepatitis b
          • Changchun, Jilin, China
            The first hospital of Jilin University
          Dec 5, 2022